Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Cerrone Gabriele M, Président Non-Exécutif. Director active across 3 companies, notably Accustem Sciences Inc.. Cumulatively, 28 reports have been published. Split: 21 buys · 0 sell. Total volume traded: €1.1m. Activity tracked since 25 April 2022. The latest transaction was filed on 12 June 2026 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Cerrone Gabriele M
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
37,500 shares@ US$4.000.17% mcap19.1% of flowAmerican Depositary SharesSEC:0001493152-22-014437:0
Canonical exit: 17 Aug 2022 (T+90)
25 of 28 declarations
About Cerrone Gabriele M
CERRONE GABRIELE M is Non-Executive Chairman and a director of Accustem Sciences Inc., OKYO Pharma Ltd and Tiziana Life Sciences Ltd. He has 22 filings in total, and across the sampled recent filings from 2022-04-27 to 2026-07-21, the transactions are acquisitions with buy volume of EUR 941379 and no sell volume indicated. The largest recent filings concern OKYO Pharma Ltd.